Healthequity Inc (NASDAQ: HQY) has a higher price-to-earnings ratio of 93.96x compared to its average ratio. HQY has 36-month beta value of 0.47. Analysts have mixed views on the stock, with 9 analysts rating it as a “buy,” 4 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for HQY is 84.20M, and currently, short sellers hold a 7.32% ratio of that float. The average trading volume of HQY on May 22, 2025 was 1.13M shares.
HQY) stock’s latest price update
Healthequity Inc (NASDAQ: HQY)’s stock price has plunge by 3.70relation to previous closing price of 98.79. Nevertheless, the company has seen a 4.92% surge in its stock price over the last five trading sessions. prnewswire.com reported 2025-05-21 that NEW YORK, May 21, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. So What: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
HQY’s Market Performance
Healthequity Inc (HQY) has experienced a 4.92% rise in stock performance for the past week, with a 19.02% rise in the past month, and a -5.66% drop in the past quarter. The volatility ratio for the week is 2.61%, and the volatility levels for the past 30 days are at 3.29% for HQY. The simple moving average for the last 20 days is 9.95% for HQY stock, with a simple moving average of 11.60% for the last 200 days.
Analysts’ Opinion of HQY
Raymond James, on the other hand, stated in their research note that they expect to see HQY reach a price target of $115, previously predicting the price at $120. The rating they have provided for HQY stocks is “Strong Buy” according to the report published on March 25th, 2025.
Mizuho gave a rating of “Outperform” to HQY, setting the target price at $126 in the report published on December 04th of the previous year.
HQY Trading at 15.01% from the 50-Day Moving Average
After a stumble in the market that brought HQY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.37% of loss for the given period.
Volatility was left at 3.29%, however, over the last 30 days, the volatility rate increased by 2.61%, as shares surge +19.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.23% upper at present.
During the last 5 trading sessions, HQY rose by +5.18%, which changed the moving average for the period of 200-days by +51.08% in comparison to the 20-day moving average, which settled at $93.19. In addition, Healthequity Inc saw 6.77% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HQY starting from SELANDER ROBERT W, who sale 5,750 shares at the price of $77.65 back on Apr 09 ’25. After this action, SELANDER ROBERT W now owns 84,969 shares of Healthequity Inc, valued at $446,513 using the latest closing price.
Stephen Neeleman, the Officer of Healthequity Inc, proposed sale 9,019 shares at $79.88 during a trade that took place back on Apr 08 ’25, which means that Stephen Neeleman is holding shares at $720,433 based on the most recent closing price.
Stock Fundamentals for HQY
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.6 for the gross margin
The net margin for Healthequity Inc stands at 0.08. The total capital return value is set at 0.05. Equity return is now at value 4.66, with 2.85 for asset returns.
Based on Healthequity Inc (HQY), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.31. The debt to equity ratio resting at 0.52. The interest coverage ratio of the stock is 2.74.
Currently, EBITDA for the company is 337.54 million with net debt to EBITDA at 2.4. When we switch over and look at the enterprise to sales, we see a ratio of 8.07. The receivables turnover for the company is 10.17for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.06.
Conclusion
To put it simply, Healthequity Inc (HQY) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
